- Home
- BOLT vs YCBD Comparison
BOLT vs YCBD Comparison
Compare BOLT & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- YCBD
- Stock Information
- Founded
- BOLT 2015
- YCBD 2015
- Country
- BOLT United States
- YCBD United States
- Employees
- BOLT N/A
- YCBD N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- BOLT Health Care
- YCBD Health Care
- Exchange
- BOLT Nasdaq
- YCBD Nasdaq
- Market Cap
- BOLT 9.4M
- YCBD 7.8M
- IPO Year
- BOLT 2021
- YCBD N/A
- Fundamental
- Price
- BOLT $5.32
- YCBD $0.70
- Analyst Decision
- BOLT Buy
- YCBD Strong Buy
- Analyst Count
- BOLT 3
- YCBD 1
- Target Price
- BOLT $47.50
- YCBD $2.00
- AVG Volume (30 Days)
- BOLT 10.9K
- YCBD 103.3K
- Earning Date
- BOLT 11-11-2025
- YCBD 08-14-2025
- Dividend Yield
- BOLT N/A
- YCBD N/A
- EPS Growth
- BOLT N/A
- YCBD N/A
- EPS
- BOLT N/A
- YCBD N/A
- Revenue
- BOLT $4,167,000.00
- YCBD $19,026,064.00
- Revenue This Year
- BOLT N/A
- YCBD $0.37
- Revenue Next Year
- BOLT N/A
- YCBD $4.95
- P/E Ratio
- BOLT N/A
- YCBD N/A
- Revenue Growth
- BOLT N/A
- YCBD N/A
- 52 Week Low
- BOLT $4.59
- YCBD $0.59
- 52 Week High
- BOLT $14.36
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- BOLT 51.15
- YCBD 43.32
- Support Level
- BOLT $5.00
- YCBD $0.68
- Resistance Level
- BOLT $5.50
- YCBD $0.73
- Average True Range (ATR)
- BOLT 0.22
- YCBD 0.05
- MACD
- BOLT 0.05
- YCBD 0.00
- Stochastic Oscillator
- BOLT 74.06
- YCBD 23.62
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.